Physicochemical and immunologic characterization of low-molecular- weight allergoids of Dactylis glomerata pollen proteins

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 54, Issue 2, 1999, Pages 128-134

  Cirkovic T D ^a   Bukilica, M N ^b   Gavrovic M D ^a   Vujcic Z M ^a   Petrovic S ^c   Jankov, R M ^a  

^a Faculty of Chemistry   (Serbia)

^b Clinical Hospital Centre   (Serbia)

^c Institute of Virology   (Serbia)

Author keywords

Allergoid; Chemical modification; Dactylis glomerata; Maleic anhydride; Orchard grass; Skin prick test; Succinic anhydride

Indexed keywords

POLLEN ANTIGEN;

ALLERGENICITY; ALLERGY; ANIMAL EXPERIMENT; ARTICLE; CLINICAL ARTICLE; FEMALE; GRASS; GRASS POLLEN; HUMAN; IMMUNOBLOTTING; IMMUNOGENICITY; IMMUNOGLOBULIN PRODUCTION; MALE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRICK TEST; PRIORITY JOURNAL; PROTEIN DETERMINATION; RABBIT;

EID: 0000670417     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1398-9995.1999.00778.x     Document Type: Article

References (26)

1. 1. Lockey RF, Benedict LM, Turkeltaub PC, Bukantz SC. Fatalities from immunotherapy (IT) and skin testing. J Allergy Clin Immunol 1987;79:660-677.
2. 2. Puttonen E, Maasch HJ, Pilstrom L. Studies on allergen and allergoid preparations from purified timothy (Phleum pratense) pollen extracts. I. Physicochemical characteristics and binding to allergen-specific human IgE. Int Arch Allergy Appl Immunol 1982;68:1-6.
3. 3. Puttonen E, Pilstrom L, Wahn U, Maasch HJ. Studies on allergen and allergoid preparations from purified timothy (Phleum pratense) pollen extracts. II. Anaphylaxis studies in rats and histamine release from human leukocytes. Int Arch Allergy Appl Immunol 1982;68:7-12.
4. 4. Puttonen E, Pilstrom L, Maasch HJ. Studies on allergen and allergoid preparations from purified timothy (Phleum pratense) pollen extracts. III. Comparative investigations by skin prick tests and nasal provocation tests. Int Arch Allergy Appl Immunol 1982;68:162-167.
5. 5. Djurup R. The subclass nature and clinical significance of the IgG antibody response in grass pollen-allergic patients undergoing allergen-specific immunotherapy. Allergy 1985;40:469-486.
6. 4 as blocking antibody. Clin Rev Allergy 1983;1:289-302.
7. 7. Peng Z, Naclerio MR, Norman SP, Adkinson NF. Quantitative IgE-and IgG-subclass responses during and after long-term immunotherapy. J Allergy Clin Immunol 1992;89:519-529.
8. 8. Meriney KD, Kothari H, Chinoy P, Grieco HM. The clinical and immunologic efficacy of immunotherapy with modified ragweed extract (allergoid) for ragweed hay fever. Ann Allergy 1986;56:34-39.
9. 9. Bousquet J, Braquemond P, Feinberg J, Guerin B, Maasch, Michel FB. Specific IgE response before and after rush immunotherapy with a standardized allergen or allergoid in grass pollen allergy. Ann Allergy 1986;56:456-459.
10. 10. Bousquet J, Dhivert H, Guerin B, et al. Double blind, placebo controlled immunotherapy with mixed grass-pollen allergoids. I. Rush immunotberapy with allergoids and standardised orchard grass pollen extract. J Allergy Clin Immunol 1987;80:591-598.
11. 11. Bousquet J, Frank E, Hejjaoui A, Maasch HJ, Michel FB, Soussana M. Double blind, placebo controlled immunotherapy with high-molecular-weight, formalinized allergoid in grass pollen allergy. Int Arch Allergy Appl Immunol 1987;82:550-552.
12. 12. Bousquet J, Maasch HJ, Hejjaoui A, Michel FB, Martinot B, Wahl R. Double blind, placebo controlled immunotherapy with mixed grass pollen allergoids. II. Comparison between parameters assessing the efficacy of immunotherapy. J Allergy Clin Immunol 1988;82:439-446.
13. 13. Bousquet J, Wahl R, Skassabroiciek W, Hejjaoui A, Michel FB, Dhivert H. Double blind, placebo controlled immunotherapy with mixed grass-pollen allergoids. III. Efficacy and safety of unfractionated and high molecular weight preparations in rhinoconjunctivitis and asthma. J Allergy Clin Immunol 1989;84:546-556.
14. 14. Bousquet J, Hejjaoui A, Soussana M, Michel FB. Double blind, placebo controlled immunotherapy with mixed grass-pollen allergoids. IV. Comparison and efficacy of 2 dosages of a high molecular weight allergoid. J Allergy Clin Immunol 1990;85:490-497.
15. 15. Tari MG, Mancino M, Ghezzi E, Frank E, Cromwell O. Immunotherapy with an alum-adsorbed Parietaria-pollen allergoid: a 2-year, double-blind, placebo-controlled study. Allergy 1997;52:65-74.
16. 16. Mistrello G, Brenna O, Roncarolo D, Gentili M, Zanoni D, Falagiani P. Monomeric chemically modified allergens: immunologic and physicochemical characterization. Allergy 1996;51:8-15.
17. 17. Mistrello G, Roncarolo D, Gentili M, Zanoni D, Falagiani P. Modified Par j I allergen from P. judaica pollen and its rate of absorption in rats. Immunol Lett 1993;40:31-35.
18. 18. Vujčić Z. Synthesis and immunochemical characterization of homoallergoids and heteroallergoids. Doctoral thesis, Belgrade, 1997.
19. 19. Lalić L. Investigation of cross sensitivity to grass pollens. Doctoral thesis, Belgrade, 1992.
20. 20. Bradford MM. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976:72:248-254.
21. 21. Harboe N, Ingild A. Immunization, isolation of immunoglobulins, estimation of antibody titer. Scand J Immunol 1973;2 Suppl 1:161-169.
22. 4 . Nature 1970;227:680-685.
23. 23. Hamilton RG, Adkinson NF. Assessment of human allergic diseases. In: Rich RR, Fleisher TA, Schwartz BD, Shearer WT, Strober W, editors. Clinical immunology: principles and practice. St Louis, MO: Mosby, 1996: 2169-2186.
24. 14. Weber K, Pringle JR, Osborn M. Measurement of molecular weight by electrophoresis on SDS-acrylamide gel. Methods Enzymol 1971;26:3-27.
25. 25. Salgado J, Casadevall G, Puingnero V, Queralt J. Characterization of allergoids from ovalbumin in vitro and in vivo. Immunology 1996;196:375-386.
26. 26. Hopp TP, Woods KR. Prediction of protein antigenic determinants from protein amino acid sequences. Proc Natl Acad Sci U S A 1981;78:3834.